Surveillance for Diseases Among Immigrants and Refugees financed in part by Prevention and Public Health Funds (PPHF)
The purpose of the program is to conduct surveillance to detect, prevent and control diseases and evaluate existing health programs to improve the health of refugees and/or immigrants that are newly arrived in the United States. The program will: 1) enhance existing surveillance networks for communicable and non-communicable diseases, including, but are not limited to: vaccine-preventable diseases, malaria, hepatitis, intestinal parasites, nutritional deficiencies and anemia; 2) evaluate the health status of refugees and/or immigrants for the purposes of informing and improving U.S. programs for overseas and the post-arrival health assessments and interventions, such as presumptive treatment for parasitic infections; and 3) improve the health of refugees and/or immigrants undergoing U.S. resettlement and protect the health of their receiving communities by controlling the spread of communicable diseases.
General information about this opportunity
Last Known Status
Centers For Disease Control and Prevention, Department of Health and Human Services
Type(s) of Assistance Offered
B - Project Grants
Patient Protection and Affordable Care Act (PL 111-148)
Public Health Service Act, Sections 301 and 317(k)(1) [42 U.S.C. 242l and 247b(k)(1)], as amended
Who is eligible to apply/benefit from this assistance?
Eligibility is limited to any domestic entity providing health care services to immigrants and refugees newly arrived in the United States.
Any U.S. state, political subdivision and U.S. territories and other public entities providing healthcare services to newly arrived refugees and immigrants will benefit
What is the process for applying and being award this assistance?
Preapplication coordination is not applicable.
This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards.
All applications that are complete and responsive to competitive supplemental grant and cooperative agreement announcements will undergo an objective review process, receive a written critique and be scored according to published review criteria. Successful applicants will receive a Notice of Award (NoA) from the CDC Procurement and Grants Office. The NoA shall be the only binding, authorizing document between the recipient and CDC. The NoA will be signed by an authorized CDC Grants Management Officer.
Contact the headquarters or regional location, as appropriate for application deadlines
Approval/Disapproval Decision Time
From 60 to 90 days.
More than 180 days. Renewals will be based upon the conditions in the funding announcement and are subject to the availability of funds.
How are proposals selected?
Applications will be reviewed for completeness by the Procurement and Grants Office (PGO) staff and for responsiveness jointly by the National Center for Emerging and Zoonotic Diseases and PGO. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicants will be notified if the application did not meet submission requirements.
How may assistance be used?
Project funds may be used for costs associated with planning, organizing, conducting, and supporting surveillance, effectiveness, and health improvement programs directed toward immigrants and refugees in the United States, and for the implementation of other program elements as described in Section 050 above and through CDC allowable and unallowable expenses.
What are the requirements after being awarded this opportunity?
Other Assistance Considerations
Formula and Matching Requirements
Statutory formula is not applicable to this assistance listing.
Matching requirements are not applicable to this assistance listing.
MOE requirements are not applicable to this assistance listing.
Length and Time Phasing of Assistance
Financial assistance is typically available for a 12-month budget period and 60-month project period. Method of awarding/releasing assistance: Lump.
Who do I contact about this opportunity?
Regional or Local Office
1600 Clifton Rd, MS E-03
Atlanta, GA 30333 US
(Cooperative Agreements) FY 18$0.00; FY 19 est $0.00; FY 20 est $0.00; FY 17$0.00; FY 16$480,000.00; - (Cooperative Agreements) FY 18$0.00; FY 19 est $0.00; FY 20 est $0.00; -
Range and Average of Financial Assistance
Awards will range from approximately $25,000 to $150,000 with an average of approximately $80,000.
Regulations, Guidelines and Literature
Examples of Funded Projects